Skip to main content
SpringerLink
Log in

Patent Ductus Arteriosus

  • Reference work entry
  • First Online:
Neonatology

Abstract

Patent ductus arteriosus (PDA) continues to be a frequent complication of extremely premature birth, despite the more generalized use of antenatal steroids, postnatal surfactant administration, and the improvement of noninvasive ventilatory strategies. Its incidence is inversely related to gestational age, such that it affects almost 60% of infants less than 28 weeks’ gestation. Spontaneous closure of the ductus occurs in 30% of infants with very low birth weight (<1500 g). When the PDA is hampering the neonate’s well-being, judicious evaluation and tailoring of the best therapeutic strategy should be performed. Ibuprofen actually seems to be the preferred drug for pharmacological treatment because of its favorable risk/benefit ratio; the therapeutic response of the most immature infants however is limited. Surgical ligation of the duct should be considered as a backup treatment due to the risks of serious complications during and after the procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 479.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 799.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abbasi S, Hirsch D, Davis J et al (2000) Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome. Am J Obstet Gynecol 182:1243–1249

    Article  CAS  PubMed  Google Scholar 

  • Ahlfors CE (2004) Effect of ibuprofen on bilirubin-albumin binding. J Pediatr 144:386–388

    Article  CAS  PubMed  Google Scholar 

  • Ahlfors CE, Marshall GD, Wolcott DK et al (2006) Measurement of unbound bilirubin by the peroxidase test using zone fluidics. Clin Chim Acta 365:78–85

    Article  CAS  PubMed  Google Scholar 

  • Amin SB, Miravalle N (2011) Effect of ibuprofen on bilirubin-albumin binding affinity in premature infants. J Perinat Med 39:55–58

    Article  CAS  PubMed  Google Scholar 

  • Andriessen P, Struis NC, Niemarkt H et al (2009) Furosemide in preterm infants treated with indomethacin for patent ductus arteriosus. Acta Paediatr 98:797–803

    Article  CAS  PubMed  Google Scholar 

  • Aranda JV, Varvarigou A, Beharry K et al (1997) Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant. Acta Paediatr 86:289–293

    Article  CAS  PubMed  Google Scholar 

  • Aranda JV, Clyman R, Cox B et al (2009) A randomized, doubleblind, placebo-controlled trial on intravenous ibuprofen l-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am J Perinatol 26:235–245

    Article  PubMed  Google Scholar 

  • Askie LM, Ballard RA, Cutter G et al (2010) Inhaled nitric oxide in preterm infants: a systematic review and individual patient data meta-analysis. BMC Pediatr 10:15

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Attridge JT, Kaufman D, Lim DS (2009) B-type natriuretic peptide to guide therapy of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 94:F178–F182

    Article  CAS  PubMed  Google Scholar 

  • Bancalari E, Claure N, Gonzalez A (2005) Patent ductus arteriosus and respiratory outcome in premature infants. Biol Neonate 88:192–201

    Article  PubMed  Google Scholar 

  • Bell EF, Acarregui MJ (2008) Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev (1):CD000503

    Google Scholar 

  • Brion LP, Soll RF (2008) Diuretics for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev (1):CD001454

    Google Scholar 

  • Brooks JM, Travadi JN, Patole SK et al (2005) Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child 90:F235–F239

    Article  CAS  Google Scholar 

  • Carmo KB, Evans N, Paradisis M (2009) Duration of indomethacin treatment of the preterm patent ductus arteriosus as directed by echocardiography. J Pediatr 155:819–822

    Article  PubMed  CAS  Google Scholar 

  • Chandrasekharan NV, Dai H, Roos KL et al (2002) COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci 99:13926–13931

    Article  CAS  PubMed  Google Scholar 

  • Chen S, Tacy T, Clyman R (2010) How useful are B-type natriuretic peptide measurements for monitoring changes in patent ductus arteriosus shunt magnitude? J Perinatol 30:780–785

    Article  CAS  PubMed  Google Scholar 

  • Chiruvolu A, Punjwani P, Ramaciotti C (2009) Clinical and echocardiographic diagnosis of patent ductus arteriosus in premature neonates. Early Hum Dev 85:147–149

    Article  PubMed  Google Scholar 

  • Choi BM, Lee KH, Eun BL et al (2005) Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics 115:e255–e261

    Article  PubMed  Google Scholar 

  • Chorne N, Jegatheesan P, Lin E et al (2007a) Risk factors for persistent ductus arteriosus patency during indomethacin treatment. J Pediatr 151:629–634

    Article  CAS  PubMed  Google Scholar 

  • Chorne N, Leonard C, Piecuch R, Clyman RI (2007b) Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics 119:1165–1174

    Article  PubMed  Google Scholar 

  • Christmann V, Liem KD, Semmekrot BA, van de Bor M (2002) Changes in cerebral, renal and mesenteric blood flow velocity during continuous and bolus infusion of indomethacin. Acta Paediatr 91:440–446

    Article  CAS  PubMed  Google Scholar 

  • Clyman RI (1996) Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. J Pediatr 128:601–607

    Article  CAS  PubMed  Google Scholar 

  • Clyman R, Chemtob S (2010) Vessel remodeling in the newborn: platelets fill the gap. Nat Med 16:33–35

    Article  CAS  PubMed  Google Scholar 

  • Clyman RI, Roman C (2007) The effects of caffeine on the preterm sheep ductus arteriosus. Pediatr Res 62:167–169

    Article  CAS  PubMed  Google Scholar 

  • Clyman RI, Waleh N, Black SM et al (1998) Regulation of ductus arteriosus patency by nitric oxide in fetal lambs: the role of gestation oxygen tension and vasa vasorum. Pediatr Res 43:633–644

    Article  CAS  PubMed  Google Scholar 

  • Clyman RI, Chen YQ, Chemtob S et al (2001) In utero remodeling of the fetal lamb ductus arteriosus: the role of antenatal indomethacin and avascular zone thickness on vasa vasorum proliferation, neointima formation, and cell death. Circulation 103:1806–1812

    Article  CAS  PubMed  Google Scholar 

  • College of Physicians for the Mother and Newborn, Section Neonatology. Federal Public Health Services, Belgium

    Google Scholar 

  • Coombs RC, Morgan ME, Durbin GM et al (1990) Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin. Arch Dis Child 65:1067–1071

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cooper-Peel C, Brodersen R, Robertson A (1996) Does ibuprofen affect bilirubin-albumin binding in newborn infant serum? Pharmacol Toxicol 79:297–299

    Article  CAS  PubMed  Google Scholar 

  • Corazza MS, Davis RF, Merrit TA et al (1984) Prolonged bleeding time in preterm infants receiving indomethacin for patent ductus arteriosus. J Pediatr 105:292–296

    Article  CAS  PubMed  Google Scholar 

  • de Vries NK, Jagroep FK, Jaarsma AS et al (2005) Continuous indomethacin infusion may be less effective than bolus infusions for ductal closure in very low birth weight infants. Am J Perinatol 2:71–75

    Article  Google Scholar 

  • de Waal K, Kluckow M (2010) Functional echocardiography; from physiology to treatment. Early Hum Dev 86:149–154

    Article  PubMed  Google Scholar 

  • del Moral T, Gonzalez-Quintero VH, Claure N et al (2007) Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extremely low birth weight infants. J Perinatol 27:154–157

    Article  CAS  Google Scholar 

  • Diot C, Kibleur Y, Desfrere L (2010) Effect of ibuprofen on bilirubin-albumin binding in vitro at concentrations observed during treatment of patent ductus arteriosus. Early Hum Dev 86:315–317

    Article  CAS  PubMed  Google Scholar 

  • Doyle LW, Ehrenkranz RA, Halliday HL (2010) dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology 98:217–224

    Article  CAS  PubMed  Google Scholar 

  • Echtler K, Stark K, Lorenz M et al (2010) Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med 16:75–82

    Article  CAS  PubMed  Google Scholar 

  • El Hajjar M, Vaksmann G, Rakza T et al (2005) Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed 90:F419–F422

    Article  PubMed  PubMed Central  Google Scholar 

  • El-Khuffash AF, Molloy EJ (2008) Influence of a patent ductus arteriosus on cardiac troponin t levels in preterm infants. J Pediatr 153:350–353

    Article  CAS  PubMed  Google Scholar 

  • Evans N (2003) Current controversies in the diagnosis and treatment of patent ductus arteriosus in preterm infants. Adv Neonatal Care 3:168–177

    Article  PubMed  Google Scholar 

  • Fanaroff AA, Stoll BJ, Wright LL et al (2007) Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 196(147):e1–e8

    Google Scholar 

  • Fowlie PW, Davis PG, McGuire W (2010) Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev (7):CD000174

    Google Scholar 

  • Gal P, Ransom JL, Weaver RL et al (1991) Indomethacin pharmacokinetics in neonates: the value of volume of distribution as a marker of permanent patent ductus arteriosus closure. Ther Drug Monit 13:42–45

    Article  CAS  PubMed  Google Scholar 

  • Gersony WM, Peckham GJ, Ellison RC et al (1983) Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 102:895–906

    Article  CAS  PubMed  Google Scholar 

  • Gonzalez A, Sosenko IR, Chandar J et al (1996) Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 128:470–478

    Article  CAS  PubMed  Google Scholar 

  • Gournay V, Savagner C, Thiriez G et al (2002) Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 359:1486–1488

    Article  CAS  PubMed  Google Scholar 

  • Gournay V, Roze JC, Kuster A et al (2004) Prophylactic ibuprofen versus placebo in very premature infants: a randomised, doubleblind, placebo-controlled trial. Lancet 364:1939–1944

    Article  CAS  PubMed  Google Scholar 

  • Green TP, Thompson TR, Johnson DE, Lock JE (1983) Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome. N Engl J Med 308:743–748

    Article  CAS  PubMed  Google Scholar 

  • Guimarães H, Rocha G, Tomé T et al (2009) Non-steroid anti-inflammatory drugs in the treatment of patent ductus arteriosus in European newborns. J Matern Fetal Neonatal Med 22(Suppl 3):77–80

    Article  PubMed  CAS  Google Scholar 

  • Halliday HL, Patterson CC, Halahakoon CW, Behalf of the European Multicenter Steroid Study Group (2001) A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics 107:232–240

    Article  CAS  PubMed  Google Scholar 

  • Hammerman C, Glaser J, Kaplan M et al (1998) Indomethacin tocolysis increases postnatal patent ductus arteriosus severity. Pediatrics 102:E56

    Article  CAS  PubMed  Google Scholar 

  • Herrera C, Holberton J, Davis P (2007) Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev (2):CD003480

    Google Scholar 

  • Hirt D, Van Overmeire B, Treluyer JM et al (2008) An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamics study. Br J Clin Pharmacol 65:629–636

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Holmström H, Hall C, Thaulow E (2001) Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr 90:184–191

    Article  PubMed  Google Scholar 

  • Ibara S, Tokunaga M, Ikenoue T et al (1994) Histologic observation of the ductus arteriosus in premature infants with intrauterine growth retardation. J Perinatol 14:411–416

    CAS  PubMed  Google Scholar 

  • Ivey KN, Srivastava D (2006) The paradoxical patent ductus arteriosus. J Clin Invest 116:2863–2865

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kabra NS, Schmidt B, Roberts RS et al (2007) Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 150:229–234

    Article  CAS  PubMed  Google Scholar 

  • Kajino H, Chen YQ, Seidner SR et al (2001) Factors that increase the contractile tone of the ductus arteriosus also regulate its anatomic remodeling. Am J Phys Regul Integr Comp Phys 281:R291–R301

    CAS  Google Scholar 

  • Katayama Y, Minami H, Enomoto M et al (2010) Antenatal magnesium sulfate and the postnatal response of the ductus arteriosus to indomethacin in extremely preterm neonates. J Perinatol 31:21–24

    Article  PubMed  CAS  Google Scholar 

  • Kluckow M, Seri I, Evans N (2008) Echocardiography and the neonatologist. Pediatr Cardiol 29:1043–1047

    Article  CAS  PubMed  Google Scholar 

  • Koch J, Hensley G, Roy L et al (2006) Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 117:1113–1121

    Article  PubMed  Google Scholar 

  • Lago P, Bettiol T, Salvadori S et al (2002) Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr 161:202–207

    Article  CAS  PubMed  Google Scholar 

  • Lee BS, Byun SY, Chung ML et al (2009) Effect of furosemide on ductal closure and renal function in indomethacin-treated preterm infants during the early neonatal period. Acta Paediatr 98:797–803

    Article  CAS  Google Scholar 

  • Lemmers PMA, Toet MC, van Bel F (2008) Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants. Pediatrics 121:142–147

    Article  PubMed  Google Scholar 

  • Lemmers PM, Molenschot MC, Evens J et al (2010) Is cerebral oxygen supply compromised in preterm infants undergoing surgical closure for patent ductus arteriosus? Arch Dis Child Fetal Neonatal Ed 95:F429–F434

    Article  PubMed  Google Scholar 

  • Little DC, Pratt TC, Blalock SE et al (2003) Patent ductus arteriosus in micropreemies and full-term infants: the relative merits of surgical ligation versus indomethacin treatment. J Pediatr Surg 38:492–496

    Article  PubMed  Google Scholar 

  • Loeliger M, Inder TE, Dalitz PA et al (2009) Developmental and neuropathological consequences of ductal ligation in the preterm baboon. Pediatr Res 65:209–214

    Article  PubMed  PubMed Central  Google Scholar 

  • Lundell BP, Sonesson SE, Cotton RB (1986) Ductus closure in preterm infants. Effects on cerebral hemodynamics. Acta Paediatr Scand Suppl 329:140–147

    Article  CAS  PubMed  Google Scholar 

  • Malviya M, Ohlsson A, Shah S (2008) Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev (1): CD003951

    Google Scholar 

  • Marshall DD, Kotelchuck M, Young TE et al (1999) Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association. Pediatrics 104:1345–1350

    Article  CAS  PubMed  Google Scholar 

  • McCurnin D, Clyman RI (2008) Effects of a patent ductus arteriosus on postprandial mesenteric perfusion in premature baboons. Pediatrics 122:e1262–e1267

    Article  PubMed  PubMed Central  Google Scholar 

  • McCurnin D, Seidner S, Chang LY et al (2008) Ibuprofen-induced patent ductus arteriosus closure: physiologic, histologic, and biochemical effects on the premature lung. Pediatrics 121:945–956

    Article  PubMed  Google Scholar 

  • McNamara PJ, Stewart L, Shivananda SP et al (2010) Patent ductus arteriosus ligation is associated with impaired left ventricular systolic performance in premature infants weighing less than 1000 g. J Thorac Cardiovasc Surg 140:150–157

    Article  PubMed  Google Scholar 

  • Mercier JC, Hummler H, Durrmeyer X et al (2010) Inhaled nitric oxide for the prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial. Lancet 376:346–354

    Article  CAS  PubMed  Google Scholar 

  • Meyers RL, Alpan G, Lin E, Clyman RI (1991) Patent ductus arteriosus, indomethacin, and intestinal distension: effects on intestinal blood flow and oxygen consumption. Pediatr Res 29:569–574

    Article  CAS  PubMed  Google Scholar 

  • Moin F, Kennedy KA, Moya FR (2003) Risk factors predicting vasopressor use after patent ductus arteriosus ligation. Am J Perinatol 20:313–320

    Article  PubMed  Google Scholar 

  • Mosalli R, Alfaleh K (2008) Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. Cochrane Database Syst Rev (1):CD006181

    Google Scholar 

  • Mosca F, Bray M, Lattanzio M et al (1997) Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 131:549–554

    Article  CAS  PubMed  Google Scholar 

  • Mosca F, Bray M, Stucchi I, Fumagalli M (2002) Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 360:1023–1024

    Article  PubMed  Google Scholar 

  • Nemerofsky SL, Parravicini E, Bateman D et al (2008) The ductus arteriosus rarely requires treatment in infants 1000 grams. Am J Perinatol 25:661–666

    Article  PubMed  Google Scholar 

  • Noori S, McCoy M, Friedlich P et al (2009) Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 123:e138–e144

    Article  PubMed  Google Scholar 

  • Norton ME, Merrill J, Cooper BA et al (1993) Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 329:1602–1607

    Article  CAS  PubMed  Google Scholar 

  • O’Donovan DJ, Baetiong A, Adams K et al (2003) Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus. J Perinatol 23:286–290

    Article  PubMed  CAS  Google Scholar 

  • Ohlsson A, Shah S (2011) Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev (7):CD004213

    Google Scholar 

  • Ohlsson A, Walia R, Shah S (2010) Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev (4):CD003481

    Google Scholar 

  • Osborn DA, Hunt RW (2007) Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev (1):CD005948

    Google Scholar 

  • Paquette L, Friedlich P, Ramanathan R, Seri I (2006) Concurrent use of indomethacin and dexamethasone increases the risk of spontaneous intestinal perforation in very low birth weight neonates. J Perinatol 26:486–492

    Article  CAS  PubMed  Google Scholar 

  • Patel J, Roberts I, Azzopardi D et al (2000) Randomized doubleblind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 47:36–42

    Article  CAS  PubMed  Google Scholar 

  • Patole SK, Kumaran V, Travadi JN et al (2007) Does patent ductus arteriosus affect feed tolerance in preterm neonates? Arch Dis Child Fetal Neonatal Ed 92:F53–F55

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Perlman JM, Hill A, Volpe JJ (1981) The effect of patent ductus arteriosus on flow velocity in the anterior cerebral arteries: ductal steal in the premature newborn infant. J Pediatr 99:767–771

    Article  CAS  PubMed  Google Scholar 

  • Pezzati M, Vangi V, Biagiotti R et al (1999) Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 135:733–738

    Article  CAS  PubMed  Google Scholar 

  • Rakza T, Magnenant E, Klosowski S et al (2007) Early hemodynamic consequences of patent ductus arteriosus in preterm infants with intrauterine growth restriction. J Pediatr 151:624–628

    Article  CAS  PubMed  Google Scholar 

  • Reese J, Waleh N, Poole SD et al (2009) Chronic in utero cyclooxygenase inhibition alters PGE2-regulated ductus arteriosus contractile pathways and prevents postnatal closure. Pediatr Res 66:155–161

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Reese J, Veldman A, Shah L et al (2010) Inadvertent relaxation of the ductus arteriosus by pharmacologic agents that are commonly used in the neonatal period. Semin Perinatol 34:222–230

    Article  PubMed  PubMed Central  Google Scholar 

  • Richards J, Johnson A, Fox G, Campbell M (2009) A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants. Pediatrics 124:e287–e292

    Article  PubMed  Google Scholar 

  • Robel-Tillig E, Knüpfer M, Vogtmann C (2003) Cardiac adaptation in small for gestational age neonates after prenatal hemodynamic disturbances. Early Hum Dev 72:123–129

    Article  PubMed  Google Scholar 

  • Romagnoli C, De Carolis MP, Papacci P et al (2000) Effects of prophylactic ibuprofen on cerebral and renal hemodynamics in very preterm neonates. Clin Pharmacol Ther 67:676–683

    Article  CAS  PubMed  Google Scholar 

  • Rouse DJ, Hirtz DG, Thom E et al (2008) A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 359:895–905

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sanjeev S, Pettersen M, Lua J et al (2005) Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates. J Perinatol 25:709–713

    Article  CAS  PubMed  Google Scholar 

  • Schmidt B, Davis P, Moddemann D et al (2001) Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 344:1966–1972

    Article  CAS  PubMed  Google Scholar 

  • Schmidt B, Roberts RS, Davis P et al (2006a) Caffeine therapy for apnea of prematurity. N Engl J Med 354:2112–2121

    Article  CAS  PubMed  Google Scholar 

  • Schmidt B, Roberts RS, Fanaroff A et al (2006b) Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J Pediatr 148:713–714

    Article  CAS  Google Scholar 

  • Schneider DJ, Moore JW (2006) Patent ductus arteriosus. Circulation 114:1873–1882

    Article  PubMed  Google Scholar 

  • Schreiber MD, Gin-Mestan K, Marks JD et al (2003) Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 349:2099–2107

    Article  CAS  PubMed  Google Scholar 

  • Seghaye MC, Grabitz R, Alzen G et al (1997) Thoracic sequelae after surgical closure of the patent ductus arteriosus in premature infants. Acta Paediatr 86:213–216

    Article  CAS  PubMed  Google Scholar 

  • Sehgal A, McNamara PJ (2009) Does echocardiography facilitate determination of hemodynamic significance attributable to the ductus arteriosus? Eur J Pediatr 168:907–914

    Article  PubMed  Google Scholar 

  • Seidner SR, Chen YQ, Oprysko PR et al (2001) Combined prostaglandin and nitric oxide inhibition produces anatomic remodeling and closure of the ductus arteriosus in the premature newborn baboon. Pediatr Res 50:365–373

    Article  CAS  PubMed  Google Scholar 

  • Seyberth HW (1983) Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in VLBW infants with symptomatic patent ductus arteriosus. J Pediatr 103:979–984

    Article  CAS  PubMed  Google Scholar 

  • Shaffer CL, Gal P, Ransom JL et al (2002) Effect of age and birth weight on indomethacin pharmacodynamics in neonates treated for patent ductus arteriosus. Crit Care Med 30:343–348

    Article  CAS  PubMed  Google Scholar 

  • Shortland DB, Gibson NA, Levene MI et al (1990) Patent ductus arteriosus and cerebral circulation in preterm infants. Dev Med Child Neurol 32:386–393

    Article  CAS  PubMed  Google Scholar 

  • Smith GC, Wu WX, Nijland MJ et al (2001) Effect of gestational age, corticosteroids, and birth on expression of prostanoid EP receptor genes in lamb and baboon ductus arteriosus. J Cardiovasc Pharmacol 37:697–704

    Article  CAS  PubMed  Google Scholar 

  • Soraisham AS, Dalgleish S, Singhal N (2010) Antenatal indomethacin tocolysis is associated with an increased need for surgical ligation of patent ductus arteriosus in preterm infants. J Obstet Gynaecol Can 32:435–442

    Article  PubMed  Google Scholar 

  • Sørensen CM, Steensberg JN, Greisen G (2010) Surgical ligation of patent ductus arteriosus in premature infants. Dan Med Bull 57:A4160

    PubMed  Google Scholar 

  • Sperandio M, Beedgen B, Feneberg R et al (2005) Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation. Pediatrics 116:1361–1366

    Article  PubMed  Google Scholar 

  • Stefano JL, Abbasi S, Pearlman SA et al (1991) Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome; effects on pulmonary compliance and ventilation. Am Rev Respir Dis 143:236–239

    Article  CAS  PubMed  Google Scholar 

  • Su BH, Lin HC, Chiun HY et al (2008) Comparison of ibuprofen and indomethacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomized controlled trial. Arch Dis Child 93:F94–F99

    Article  Google Scholar 

  • Szymankiewicz M, Hodgman JE, Siassi B, Gadzinowski J (2004) Mechanics of breathing after surgical ligation of patent ductus arteriosus in newborns with respiratory distress syndrome. Biol Neonate 85:32–36

    Article  PubMed  Google Scholar 

  • Tatli MM, Kumral A, Duman N et al (2004) Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in two very-low-birthweight infants. Acta Paediatr 93:999–1001

    Article  CAS  PubMed  Google Scholar 

  • Thalji AA, Carr I, Yeh TF et al (1980) Pharmacokinetics of intravenously administered indomethacin in premature infants. J Pediatr 97:995–1000

    Article  CAS  PubMed  Google Scholar 

  • Thomas RL, Parker GC, Van Overmeire B, Aranda JV (2005) A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 164:135–140

    Article  CAS  PubMed  Google Scholar 

  • Toyoshima K, Momma K, Nakanishi T (2010) In vivo dilatation of the ductus arteriosus induced by furosemide in the rat. Pediatr Res 67:173–176

    Article  CAS  PubMed  Google Scholar 

  • Travadi J, Simmer K, Ramsay J et al (2006) Patent ductus arteriosus in extremely preterm infants receiving phototherapy: does shielding the chest make a difference? A randomized, controlled trial. Acta Paediatr 95:1418–1423

    Article  PubMed  Google Scholar 

  • Van Overmeire B, Follens I, Hartmann S et al (1997) Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child 76:F179–F184

    Article  Google Scholar 

  • Van Overmeire B, Smets K, Lecoutere D et al (2000) A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 343:674–681

    Article  PubMed  Google Scholar 

  • Van Overmeire B, Van de Broek H, Van Laer P et al (2001a) Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr 138:205–211

    Article  PubMed  Google Scholar 

  • Van Overmeire B, Touw D, Schepens PJC et al (2001b) Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther 70:336–343

    Article  PubMed  Google Scholar 

  • Van Overmeire B, Allegaert K, Casaer A et al (2004a) Prophylactic ibuprofen in premature infants: a multicentre, randomised, doubleblind, placebo-controlled trial. Lancet 364:1945–1954

    Article  PubMed  CAS  Google Scholar 

  • Van Overmeire B, Vanhagendoren S, Schepens PJ, Ahlfors CE (2004b) The influence of ibuprofen-lysine on unbound bilirubin plasma levels in preterm neonates. Pediatr Res 55:474A

    Google Scholar 

  • Watterberg KL, Scott SM, Backstrom C et al (2000) links between early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus. Pediatrics 105:320–324

    Article  CAS  PubMed  Google Scholar 

  • Watterberg KL, Gerdes JS, Cole CH et al (2004) Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 114:1649–1657

    Article  PubMed  Google Scholar 

  • Yokoyama U, Minamisawa S, Quan H et al (2006) Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus. J Clin Invest 116:3026–3034

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neonatology Service, Erasmus Hospital Université Libre de Bruxelles, Brussels, Belgium

    Bart Van Overmeire

Authors
  1. Bart Van Overmeire
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pediatrics Obstetrics and Reproductive Medicine, University of Siena, Siena, Italy

    Giuseppe Buonocore

  2. Department of Pediatrics Obstetrics and Reproductive Medicine, University of Siena, Siena, Italy

    Rodolfo Bracci

  3. Liverpool Women’s Hospital Neonatal Unit, Liverpool, UK

    Michael Weindling

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Van Overmeire, B. (2018). Patent Ductus Arteriosus. In: Buonocore, G., Bracci, R., Weindling, M. (eds) Neonatology. Springer, Cham. https://doi.org/10.1007/978-3-319-29489-6_219

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-29489-6_219

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-29487-2

  • Online ISBN: 978-3-319-29489-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation